We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LQDA market cap is 972.4M. The company's latest EPS is USD -1.0325 and P/E is -12.39.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.17M | 5.36M | 4.49M | 4.79M | 3.68M |
Operating Income | -8.83M | -6.5M | -9.23M | -22.47M | -15.25M |
Net Income | -9.09M | -6.53M | -11.75M | -23.52M | -15.79M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 8.07M | 740k | 12.85M | 15.94M | 17.49M |
Operating Income | -46.82M | -59.09M | -33.8M | -38.77M | -73.38M |
Net Income | -47.58M | -59.76M | -34.58M | -41.02M | -78.5M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 132.57M | 129.2M | 128.92M | 121.6M | 111.64M |
Total Liabilities | 37.53M | 38.78M | 47.28M | 60.94M | 63.64M |
Total Equity | 95.03M | 90.42M | 81.64M | 60.66M | 48.01M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 68.84M | 99.53M | 93.73M | 129.2M | 118.33M |
Total Liabilities | 33.89M | 28.45M | 28.46M | 38.78M | 71.04M |
Total Equity | 34.95M | 71.09M | 65.27M | 90.42M | 47.29M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -23.99M | -28.59M | -8.46M | -14.02M | -25.58M |
Investing | -96k | -587k | -364k | -607k | -11.08M |
Financing | 64.91M | 64.96M | 9.95M | 9.54M | 19.61M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -48.28M | -54.15M | -34.04M | -28.59M | -41.56M |
Investing | -1.85M | 248k | -107k | -587k | -11.29M |
Financing | 66.39M | 63.42M | 26.32M | 64.96M | 43.25M |
Market Cap | 972.4M |
Price to Earnings Ratio | -12.39 |
Price to Sales Ratio | 55.61 |
Price to Cash Ratio | 11.62 |
Price to Book Ratio | 20.56 |
Dividend Yield | - |
Shares Outstanding | 76.03M |
Average Volume (1 week) | 644.02k |
Average Volume (1 Month) | 814.43k |
52 Week Change | 93.20% |
52 Week High | 16.99 |
52 Week Low | 5.71 |
Spread (Intraday) | 1.17 (8.85%) |
Company Name | Liquidia Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.liquidia.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions